In liver metastases, SLAMF3 inhibited the phagocytosis of CRC cells by macrophages and suppressed M1 macrophage polarization while also reducing the proportion of clinically beneficial C1QC+ TAMs. This evidence concerns the gene LY9 and colorectal carcinoma.